Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Neurolink, Inc.
Despite the availability of more than 20 anti-epilepsy drugs, surgery, and a neurostimulation therapy that’s been available for 15 years, a large proportion of the three million patients in the US with epilepsy continue to have seizures. Emerging device companies aim to provide a solution for them.
Start-Up's monthly comprehensive review of emerging life science companies that have received venture funding during the month, including companies in the pharmaceutical, medical device, diagnostic and research instrumentation and reagent sectors.
A roundup of recent medtech strategic alliances, mergers & acquisitions and financings.
- Drug Delivery
- Implantable Devices